New cancer chemotherapeutic agents

Cancer. 1972 Dec;30(6):1639-46. doi: 10.1002/1097-0142(197212)30:6<1639::aid-cncr2820300633>3.0.co;2-4.
No abstract available

Publication types

  • Review

MeSH terms

  • Aldehydes / therapeutic use
  • Amides / therapeutic use
  • Amines / therapeutic use
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Asparaginase / therapeutic use
  • Azacitidine / therapeutic use
  • Azaguanine / therapeutic use
  • Bleomycin / therapeutic use
  • Carmustine / therapeutic use
  • Chlorides / therapeutic use
  • Cyclization
  • Cyclohexanes / therapeutic use
  • Cytarabine / therapeutic use
  • Cytidine / therapeutic use
  • Doxorubicin / therapeutic use
  • Glycosides / therapeutic use
  • Humans
  • Hydroxyurea / therapeutic use
  • Imidazoles / therapeutic use
  • Leukemia, Lymphoid / drug therapy
  • Leukemia, Myeloid / drug therapy
  • Mice
  • Nitrosourea Compounds / therapeutic use
  • Picolinic Acids / therapeutic use
  • Platinum / therapeutic use
  • Podophyllotoxin / therapeutic use
  • Streptozocin / therapeutic use
  • Thiosemicarbazones / therapeutic use
  • Triazenes / therapeutic use

Substances

  • Aldehydes
  • Amides
  • Amines
  • Antineoplastic Agents
  • Chlorides
  • Cyclohexanes
  • Glycosides
  • Imidazoles
  • Nitrosourea Compounds
  • Picolinic Acids
  • Thiosemicarbazones
  • Triazenes
  • Cytarabine
  • Bleomycin
  • Platinum
  • Cytidine
  • Streptozocin
  • Doxorubicin
  • Asparaginase
  • Podophyllotoxin
  • Azacitidine
  • Azaguanine
  • Carmustine
  • Hydroxyurea